Determination of the impact of several herbs in the treatment of Dementia

Pharmacology, Toxicology and Pharmaceutical Science

1. Alzheimer's Disease 100%
2. Scopolamine 90%
3. Antioxidant 72%
4. Anti-Inflammatory Drug 54%
5. Diseases 45%
6. Ginkgo Biloba 45%
7. Withania somnifera 45%
8. Plant Extract 36%
9. Curcumin 27%
10. Prevalence 27%
11. Mild Cognitive Impairment 27%
12. Crocus sativus 27%
13. Neuroprotective Agent 18%
14. Centella asiatica 18%
15. Catalase 18%
16. Neurotransmitter 18%
17. Acetylcholinesterase 18%
18. Vinpocetine 18%
19. Phytochemical 18%
20. Donepezil 18%
21. Malonaldehyde 18%
22. Memory Disorder 18%
23. Transgenic Mouse 18%
24. Glutathione 18%
25. Mouse Model 18%
26. Antidepressant 9%
27. Diabetes Mellitus 9%
28. Clinical Trial 9%
29. Bipolar Disorder 9%
30. Cholinergic Receptor Stimulating Agent 9%
31. Dyslipidemia 9%
32. Serotonin 9%
33. Preclinical Study 9%
34. Herbaceous Agent 9%
35. Folic Acid 9%
36. Randomized Controlled Trial 9%
37. Structure Activity Relationship 9%
38. Noradrenalin 9%
39. Medicinal Plant 9%
40. Bioavailability 9%
41. Bacopa monnieri 9%
42. Dichloromethane 9%
43. Saponin 9%
44. Distilled Water 9%
45. Nervous System Inflammation 9%
46. Muscarinic Acetylcholine Receptor Antagonist 9%
47. Fatty Acid 9%
48. Disease Model 9%
49. Flavonoid 9%
50. Normal Human 9%
51. Salicylate Sodium 9%
52. Polyphenol 9%
53. Convolvulus 9%
54. Bacopa Monnieri Extract 9%
55. Neuroprotection 9%
56. Amyloid Protein 9%
57. Hexane 9%
58. Table Salt 9%
59. Treatment Group 9%
60. Amino Acid 9%
61. Cognitive Defect 9%
62. Methanol 9%
63. Dopamine Receptor Stimulating Agent 9%
64. Scanning Electron Microscopy 9%
65. Vitamin B12 9%
66. Adverse Event 9%
67. Enzyme 9%
68. Malnutrition 9%
69. Ethanol 9%